At IEQ Capital, continuous learning remains central to how we deliver value to clients. IEQ Elevate, our internal professional development platform, is designed to deepen expertise, foster long-term growth, and enhance client experience. As a predominantly employee-owned firm, we believe that education, ownership, and a values-driven culture create a direct benefit for those we serve.
In a recent conversation with Pinegrove Venture Partners, our investment research team explored the ongoing evolution of the venture secondaries market. Once viewed narrowly as a means for early liquidity, the market today plays a central role in institutional venture portfolios. Through company tenders, GP-led continuation funds, and LP interest sales, we believe venture secondaries are helping reprice assets, extend runway for high-quality companies, and provide selective access to innovation at valuations. This article outlines the evolving opportunity set and IEQ Capital’s perspective on how to navigate this segment with discipline and strategic intent.
Introduction
Liquidity constraints and valuation resets across private markets have elevated the role of secondaries, particularly in venture capital. As holding periods extend and exit markets remain challenged, we believe the venture secondaries space has emerged not only as a tactical solution for sellers, but also as a structurally attractive entry point for long-term allocators. IEQ Capital’s relationships with institutional managers in this market offer a differentiated window into evolving deal structures and emerging investment themes.
Understanding Company Tenders in Venture Capital
One of the most visible tools in the venture secondaries space is the tender offer, a company-facilitated liquidity event that allows multiple stakeholders, such as employees and early investors, to sell their shares in a coordinated process. These transactions are typically structured alongside a new primary financing round and reflect the company’s intent to manage cap table dynamics while offering liquidity without pursuing a new round of financing or full exit.1
Fund managers like Pinegrove view tenders as one of the preferred entry mechanisms. These transactions often involve purchasing shares from early employees or seed investors and may not include direct engagement with company management. However, because tenders are typically facilitated with company support, they offer greater transparency and alignment than traditional secondaries. Pricing is generally negotiated at levels that reflect more conservative assumptions than those embedded in primary financing rounds, providing a potentially more measured entry point compared to primary rounds or IPOs. For the company, tenders also represent a less dilutive liquidity option, allowing them to retain capitalization discipline while meeting shareholder needs.1
Market Trends Shaping Today’s Opportunity Set
The current venture secondaries environment reflects a broader shift, not just in valuations, but in the structural maturity of the asset class. Several trends are reinforcing the strategic relevance of this market:
- Corporate Venture Activity Is Becoming More Dispersed: Over the past decade, many corporations have built substantial venture portfolios, some with notable success, others with more limited strategic or financial outcomes. Today, activity is increasingly bifurcated: some corporate venture arms are scaling back or divesting legacy positions as part of broader capital reallocation efforts, while others, such as Nvidia, remain highly active and strategic in their deployment. This divergence is contributing to a more heterogeneous secondaries market, with a mix of motivated sellers and long-term participants shaping the current opportunity set.¹
- Continuation Funds are Reshaping the Exit Timeline: While continuation vehicles have become a significant part of the private equity secondary market, they are only more recently gaining traction in venture capital. These structures allow general partners (GPs) to extend ownership of high-conviction companies by transferring them into a new vehicle backed by secondary capital. For existing investors, they offer a liquidity option; for GPs, they provide additional runway to support value creation. A notable example came in 2024, when Lightspeed completed one of the largest venture continuation transactions to date, transferring over $1.5 billion in assets into a new fund backed by Lexington Partners.3 This transaction reflects a growing willingness to use continuation funds as an institutional solution for longer growth horizons and portfolio optimization.
- Public-Private Valuation Dislocation Remains a Pricing Opportunity: While private market valuations can lag adjustments seen in the public markets, secondary transactions often provide buyers with the opportunity to reprice exposure more in line with current market fundamentals. Unlike primary rounds, which may reflect future-oriented growth expectations or require investors to participate at a predetermined valuation established by the company, secondary buyers can transact at negotiated discounts to fair market value (FMV), improving price discipline. Managers like Pinegrove highlight this as a key advantage in today’s environment, particularly when underwriting companies with longer time horizons to exit.4
- Investor Behavior Continues to Evolve in Secondaries: Secondary market participants are increasingly sophisticated. Sellers are not simply seeking to exit, but to rebalance portfolios or raise liquidity for new allocations. There is growing familiarity with transaction types like partial sales, structured tenders, and fund recapitalizations, creating a more fluid, dynamic market environment. 5
Strategic Considerations in Today’s Venture Secondaries Market
Engagement with institutional secondaries managers, including Pinegrove, continues to reinforce several key dynamics shaping today’s opportunity set. Across the market, sophisticated allocators are emphasizing a few consistent themes:
- Pacing and Patience Remain Critical: Venture secondaries are inherently cyclical. The volume and pricing of quality deal flow are often driven by shifts in market sentiment, public comparables, and liquidity needs among legacy investors. Rather than deploying capital continuously, experienced managers tend to adopt a research-driven, opportunistic approach, waiting for periods when pricing dislocation and seller motivation align. This disciplined pacing helps mitigate valuation risk and allows for more attractive long-term positioning.1
- Concentration Reflects Conviction: In contrast to broad portfolio diversification, some institutional buyers are increasingly pursuing concentrated secondary interests, often aligning with high-conviction managers or late-stage companies with clearer exit paths. Pinegrove, for example, emphasizes a concentrated approach as a core part of its underwriting strategy, targeting fewer, higher-conviction opportunities with deeper diligence. This reflects a shift toward deeper underwriting and selective exposure, particularly in environments where high-quality assets are scarce.1
- Valuation Anchoring to Public Market Multiples: A consistent theme in manager conversations is the disconnect between private company fair market values and public market benchmarks. In the current environment, secondary investors are using public market multiples as a reference point to underwrite deals more conservatively, often acquiring stakes at meaningful discounts to FMV. This dynamic is particularly relevant in sectors where exit timelines are long and valuation transparency is limited. 1
Risks to Consider: While secondaries present attractive features, investors must remain mindful of key risks: Market Volatility, where pricing dynamics can shift in response to broader capital market conditions; Execution Risk, as thorough diligence is required to evaluate underlying asset quality and fund performance; Liquidity Constraints, since exit timing may be uncertain and is typically tied to fund life cycles; and Valuation Variability, because lagged net asset values may not reflect real-time market conditions. Considerations specific to tender offers include Limited Liquidity Window, as tender offers are typically structured as time-limited opportunities and may not recur, meaning investors who do not participate may not have another near-term liquidity option; Pricing Risk, since tender pricing is often negotiated at a discount to fair market value and may not reflect the company’s long-term growth potential or subsequent financing valuations; and Information Asymmetry, as investors participating in tenders may have access to less information than company insiders or lead investors, which could impact pricing dynamics and decision-making.
Why Venture Secondaries Matter for UHNW Families
For UHNW investors, the venture secondaries market today reflects structural maturation, not distress. The increased use of continuation vehicles, tender-led processes, and portfolio divestitures from corporate venture programs has expanded the opportunity set for institutional capital. These trends point to a more transparent and disciplined marketplace, where long-duration investors can access high-growth companies at potentially more attractive valuations. 1
In addition to pricing advantages, venture secondaries may offer a more compelling risk-reward profile compared to traditional venture strategies. Because investors typically acquire shares in more mature companies, often at a discount to prior valuations, there may be reduced exposure to early-stage risk. The structure of these transactions can also help mitigate the J-curve, with earlier distributions and greater visibility into operating performance. 1
Closing Thoughts
As exit timelines extend and private markets undergo valuation normalization, venture secondaries represent a differentiated approach to accessing innovation. Structured processes such as tenders and continuation funds offer potential for enhanced transparency, liquidity, and price discovery. These developments are reshaping the way long-term investors engage with the venture ecosystem.
IEQ Capital continues to monitor these trends closely and, where appropriate, may incorporate venture secondaries into client portfolios as part of a long-term, research-driven investment framework.
1. IEQ & Pinegrove Q3 Market Update Call (July 2025).
2. PitchBook Data (February 2025).
3. Lazard Financial Advisory (March 2025).
4. Venture Capital Journal (July 2025).
5. Morgan Stanley Private Capital Markets (March 2025).
Secondaries
Concentration Risk: Strategies pursuing GP-led deals may have more concentration risk than a traditional secondaries fund.
Liquidity Risk: Exit strategies are typically contingent on capital markets and prevailing appetite for risk, which may ebb and flow with the cycle.
Macro Risk: Macro factors including interest rates, inflation, or economic growth may lead to materially different return outcomes for the sector, particularly if there is a material impact to earnings outlooks.
Mark to Market Risk: Portfolios may contain liquid securities which are typically more volatile than private investments.
Venture / PE / Growth Equity
Execution Risk: Private equity and venture capital investments often rely on operational expertise to add value to portfolio companies. There is risk that the operational team cannot deliver as expected.
J-curve Risk: PE and VC funds typically experience a more severe j-curve than other alternative investment strategies due to longer timelines to appreciation and lack of early distributable cash flow.
Macro Risk: Multiple contraction, erosion of consumer demand, and increased costs of leverage could negatively impact the fund.
Some of the views and opinions expressed during the event and in the referenced materials are those of Pinegrove Venture Partners and do not necessarily reflect the views of IEQ Capital, LLC (“IEQ”).
IEQ Capital, LLC has a business relationship with Pinegrove Venture Partners
This material is as of the date indicated, not complete, and subject to change. Additional information is available upon request. No representation is made with respect to the accuracy, completeness, or timeliness of information, and IEQ assumes no obligation to update or revise such information. The information set forth herein has been developed internally and/or obtained or derived from sources believed by IEQ Capital, LLC (“IEQ Capital”) to be reliable. However, IEQ Capital does not make any representation or warranty, express or implied, as to the information’s accuracy or completeness, nor does IEQ Capital recommend that the attached information serve as the basis of any investment decision. This document has been provided to you solely for information purposes and does not constitute an offer or solicitation of an offer, or any advice or recommendation, to purchase any securities or other financial instruments, and may not be construed as such. It is not intended to be, nor should it be construed or used as investment, tax, accounting, legal or financial advice. IEQ provides no assurance or guarantee that any investment will be successful or that any returns will be achieved. PAST RESULTS ARE NOT NECESSARILY INDICATIVE OF FUTURE RESULTS.